Medical Genetic Diagnosis and Therapy Center of Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defect, Fuzhou, China.
Medical Technology and Engineering College of Fujian Medical University, Fuzhou, China.
J Clin Lab Anal. 2022 Oct;36(10):e24696. doi: 10.1002/jcla.24696. Epub 2022 Sep 13.
There is a high carrying rate of α-thalassemia in Fujian province. However, there are few large-scale studies on the correlation between genotype and phenotype in Fujian province. The purpose of this study was to analyze the phenotype and genotype in a cohort of 2923 patients with α-thalassemia in Fujian province, so as to provide reference data for screening and diagnosis of α-thalassemia in Fujian province.
The genotype of α-thalassemia was detected by PCR reverse dot blot assay, gap-PCR, single PCR, nested PCR, and sequencing. Clinical and hematological indices of 2923 patients were collected, and the correlation between genotype and phenotype was analyzed.
Among 10,350 patients, 2923 cases were found with α-thalassemia, with a detection rate of 28.24%. Among them, -- /αα was the most common genotype, accounting for 64.80%. In addition, rare α-thalassemia genotypes were detected in Fujian province, including -- /αα (0.41%), HKαα/-- (0.03%), and the novel α-thalassemia gene mutation CD5 (GCC>ACC) (HGVS named HBA1: c.16G>A) (0.03%). Patients with deletional genotypes of α-thalassemia were found to have higher RBC and lower Hb, MCV, MCH, and HbA2 than patients with non-deletional genotypes of α-thalassemia (p < 0.05).
The clinical phenotype of α-thalassemia is influenced by molecular mechanisms. HBA1: c.16G>A mutation is a novel mutation that was first reported in Fujian province, which enriches the human hemoglobin mutation spectrum.
福建省 α-地中海贫血的携带率较高。然而,针对福建省基因型与表型相关性的大规模研究较少。本研究旨在分析福建省 2923 例α-地中海贫血患者的表型和基因型,为福建省α-地中海贫血的筛查和诊断提供参考数据。
采用 PCR 反向斑点杂交、gap-PCR、单管 PCR、巢式 PCR 和测序法检测α-地中海贫血基因型。收集 2923 例患者的临床和血液学指标,分析基因型与表型的相关性。
在 10350 例患者中,发现 2923 例α-地中海贫血,检出率为 28.24%。其中,--/αα基因型最常见,占 64.80%。此外,还在福建省检测到罕见的α-地中海贫血基因型,包括--/αα(0.41%)、HKαα/--(0.03%)和新的α-地中海贫血基因突变 CD5(GCC>ACC)(HGVS 命名为 HBA1:c.16G>A)(0.03%)。缺失型α-地中海贫血基因型患者的 RBC 较高,Hb、MCV、MCH 和 HbA2 较低,而非缺失型α-地中海贫血基因型患者的 RBC 较低,Hb、MCV、MCH 和 HbA2 较高(p<0.05)。
α-地中海贫血的临床表型受分子机制影响。HBA1:c.16G>A 突变是首次在福建省报道的新突变,丰富了人类血红蛋白突变谱。